Bulletin
Investor Alert

New York Markets Close in:

Horizon Therapeutics PLC

NAS: HZNP

GO
/marketstate/country/us

Market open

 --Real time quotes

May 24, 2022, 12:20 p.m.

/zigman2/quotes/206690250/composite

$

88.72

Change

+1.34 +1.53%

Volume

Volume 637,764

Real time quotes

/zigman2/quotes/206690250/composite

Previous close

$ 87.38

$ 88.72

Change

+1.34 +1.53%

Day low

Day high

$87.12

$89.45

Open

52 week low

52 week high

$82.51

$120.54

Open

Paul W. Hoelscher

Paul W. Hoelscher is on the board of Reneo Pharmaceuticals, Inc. and Chief Financial Officer & Executive Vice President at Horizon Therapeutics Plc and Trustee-Illinois Chapter at The Leukemia & Lymphoma Society, Inc.

In his past career Paul W. Hoelscher occupied the position of Chief Financial Officer & Secretary of Hyperion Therapeutics, Inc., Chief Financial Officer of Horizon Pharma, Inc., Vice President-Finance at Alberto-Culver LLC, Senior Vice President-Finance & Treasury at OfficeMax, Inc. and Vice President & Controller at Alberto-Culver LLC.

Paul W. Hoelscher received an undergraduate degree from the University of Illinois At Urbana–Champaign.

Transactions

Date Shares Transaction Value
04/20/2022 21,542   Disposition at $115.17 per share. 2,480,993
04/20/2022 28,458   Disposition at $114.36 per share. 3,254,457
04/20/2022 50,000   Derivative/Non-derivative trans. at $22.14 per share. 1,107,000
04/06/2022 91,710   Disposition at $110.01 per share. 10,089,018
04/06/2022 215,335   Disposition at $110.01 per share. 23,689,004
04/06/2022 185,060   Derivative/Non-derivative trans. at $22.14 per share. 4,097,228
04/06/2022 30,275   Derivative/Non-derivative trans. at $15.96 per share. 483,189
03/25/2022 663   Disposition at $110 per share. 72,930
03/24/2022 1,481   Disposition at $110 per share. 162,910
03/23/2022 11,699   Disposition at $110.01 per share. 1,287,007
03/23/2022 26,090   Disposition at $110 per share. 2,869,900
03/23/2022 26,090   Derivative/Non-derivative trans. at $15.96 per share. 416,396
03/07/2022 172,226   Gift at $0 per share. 0
03/07/2022 172,226   Gift at $0 per share. 0
03/07/2022 66,626   Gift at $0 per share. 0
03/07/2022 66,626   Gift at $0 per share. 0
01/21/2022 2,463   Derivative/Non-derivative trans. at $86.42 per share. 212,853
01/21/2022 5,558   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2022 50,666   Derivative/Non-derivative trans. at $101.84 per share. 5,159,826
01/05/2022 47,375   Award at $0 per share. 0
01/05/2022 66,822   Derivative/Non-derivative trans. at $0 per share. 0
12/28/2021 8,575   Disposition at $110 per share. 943,250
12/28/2021 8,575   Derivative/Non-derivative trans. at $15.96 per share. 136,857
12/03/2021 1,049   Gift at $0 per share. 0
08/25/2021 6,163   Gift at $0 per share. 0
08/25/2021 6,163   Gift at $0 per share. 0
07/28/2021 3,858   Derivative/Non-derivative trans. at $102.5 per share. 395,445
07/28/2021 8,708   Award at $0 per share. 0
05/14/2021 102,925   Disposition at $90.01 per share. 9,264,280
02/17/2021 1,045   Derivative/Non-derivative trans. at $87.17 per share. 91,093
02/17/2021 2,358   Award at $0 per share. 0
02/01/2021 3,094   Gift at $0 per share. 0
02/01/2021 3,094   Gift at $0 per share. 0
01/21/2021 2,462   Derivative/Non-derivative trans. at $77.43 per share. 190,633
01/21/2021 5,556   Derivative/Non-derivative trans. at $0 per share. 0
01/19/2021 169,132   Gift at $0 per share. 0
01/19/2021 169,132   Gift at $0 per share. 0
01/05/2021 134,698   Derivative/Non-derivative trans. at $73.28 per share. 9,870,670
01/05/2021 205,638   Award at $0 per share. 0
01/05/2021 98,192   Derivative/Non-derivative trans. at $0 per share. 0
08/24/2020 1,823   Disposition at $76.23 per share. 138,968
08/24/2020 27,753   Disposition at $75.73 per share. 2,101,735
05/05/2020 104,994   Disposition at $38 per share. 3,989,772
02/26/2020 11,452   Gift at $0 per share. 0
02/26/2020 11,452   Gift at $0 per share. 0
02/19/2020 6,649   Derivative/Non-derivative trans. at $36.06 per share. 239,763
02/19/2020 15,007   Award at $0 per share. 0
02/14/2020 226,043   Gift at $0 per share. 0
02/14/2020 226,043   Gift at $0 per share. 0
01/21/2020 2,461   Derivative/Non-derivative trans. at $38.25 per share. 94,134
01/21/2020 5,555   Award at $0 per share. 0
01/05/2020 69,321   Derivative/Non-derivative trans. at $36.1 per share. 2,502,489
01/05/2020 72,376   Award at $0 per share. 0
01/05/2020 83,678   Derivative/Non-derivative trans. at $0 per share. 0
10/15/2019 10,000   Disposition at $28 per share. 280,000
10/15/2019 10,000   Disposition at $28.01 per share. 280,100
08/30/2019 1,359   Disposition at $28 per share. 38,052
08/22/2019 4,516   Derivative/Non-derivative trans. at $22.14 per share. 99,984
08/22/2019 25,060   Derivative/Non-derivative trans. at $15.96 per share. 399,957
08/21/2019 14,201   Disposition at $28.01 per share. 397,771
08/21/2019 56,702   Disposition at $28 per share. 1,587,656
03/23/2019 13,733   Derivative/Non-derivative trans. at $26.84 per share. 368,594
03/23/2019 31,000   Derivative/Non-derivative trans. at $0 per share. 0
02/20/2019 32,064   Derivative/Non-derivative trans. at $21.54 per share. 690,659
02/20/2019 72,375   Award at $0 per share. 0
01/05/2019 29,419   Derivative/Non-derivative trans. at $20.39 per share. 599,854
01/05/2019 65,695   Derivative/Non-derivative trans. at $0 per share. 0
06/23/2018 8,860   Derivative/Non-derivative trans. at $17.67 per share. 156,557
06/23/2018 20,000   Derivative/Non-derivative trans. at $0 per share. 0
03/23/2018 13,733   Derivative/Non-derivative trans. at $13.86 per share. 190,340
03/23/2018 31,000   Derivative/Non-derivative trans. at $0 per share. 0
06/23/2017 9,140   Derivative/Non-derivative trans. at $11.73 per share. 107,213
06/23/2017 20,000   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Timothy P. Walbert
Chairman, President & Chief Executive Officer
Mr. Aaron L. Cox
Chief Financial Officer & Executive Vice President
Dr. Karin Rosen
Chief Scientific Officer
Dr. Elizabeth H. Z. Thompson
Executive Vice President-Research & Development
Dr. Jeffrey W. Sherman
Chief Medical Officer & Executive Vice President
Mr. Michael A. DesJardin
Executive VP-Technical Operations & Quality
Dr. Jeffrey D. Kent
Executive VP-Medical Affairs & Outcomes Research
Mr. Andy Pasternak
Chief Strategy Officer & Executive Vice President
Ms. Holly Copeland
Senior Director-Corporate Social Responsibility
Ms. Marilyn Vetter
Group Vice President-Market Access
Mr. Vikram Karnani
President-International & Executive Vice President
Mr. Miles W. McHugh
Chief Accounting Officer & Senior Vice President
Ms. Tina Ventura
Chief Investor Relations Officer & Senior VP
Ms. Jane Gonnerman
Chief of Staff & Group Vice President-Development
Ms. Irina P. Konstantinovsky
EVP, Chief Human Resources & Diversity Officer
Mr. David Caraher
Secretary
Mr. Sean M. Clayton
Executive Vice President & General Counsel
Dr. Susan Mahony
Independent Director
Mr. Michael G. Grey
Lead Independent Director
Dr. Jeff Himawan
Independent Director
Mr. William Francis Daniel
Independent Director
Ms. Pascale Witz
Independent Director
Dr. James Samuel Shannon
Independent Director
Mr. H. Thomas Watkins
Independent Director
Mr. Gino Santini
Independent Director
Link to MarketWatch's Slice.